Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions
収録刊行物
-
- Ann Oncol
-
Ann Oncol 12 1133-1137, 2001